KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,336,363 | +577.7% | 61,129 | +769.1% | 0.01% | +500.0% |
| Q2 2023 | $1,525,322 | -44.4% | 7,034 | -53.4% | 0.00% | -33.3% |
| Q1 2023 | $2,744,217 | +56.7% | 15,108 | +69.5% | 0.00% | +50.0% |
| Q4 2022 | $1,751,363 | -39.7% | 8,914 | -30.9% | 0.00% | -50.0% |
| Q3 2022 | $2,903,000 | -68.0% | 12,905 | -82.6% | 0.00% | -60.0% |
| Q3 2021 | $9,082,000 | +74.9% | 74,241 | +63.0% | 0.01% | +66.7% |
| Q2 2021 | $5,192,000 | +43.9% | 45,550 | +51.8% | 0.01% | +50.0% |
| Q1 2021 | $3,607,000 | +4.9% | 29,997 | -2.8% | 0.00% | -33.3% |
| Q2 2020 | $3,440,000 | +60.9% | 30,860 | +3.9% | 0.01% | +20.0% |
| Q1 2020 | $2,138,000 | – | 29,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |